Young David has filed 24 insider transactions across 1 company since January 2024.
Most recent transaction: a purchase of 1810 shares of Processa Pharmaceuticals, Inc. ($PCSA) on March 31, 2026.
Activity breakdown: 4 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | P | Common Stock | 1810 | $2.54 | 12,978.0000 | 56,644,223 | 16.21% | 0.00% |
| Jan. 1, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | M | Restricted Stock Units | 49 | $0.00 | 0.0000 | 56,644,223 | 100.00% | 0.00% |
| Jan. 1, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | M | Common Stock | 49 | $0.00 | 11,168.0000 | 56,644,223 | 0.44% | 0.00% |
| Oct. 1, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | A | Restricted Stock Units | 111000 | $0.00 | 111,000.0000 | 5,269,240 | 9999.99% | 2.11% |
| Oct. 1, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | A | Stock Options (Right to Buy) | 333000 | $0.00 | 333,000.0000 | 5,269,240 | 9999.99% | 6.32% |
| July 24, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | A | Restricted Stock Units | 1813133 | $0.00 | 1,821,016.0000 | 5,269,240 | 9999.99% | 34.41% |
| April 1, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | F | Common Stock | 5345 | $0.41 | 277,647.0000 | 5,269,240 | 1.89% | 0.10% |
| April 1, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | M | Common Stock | 17272 | $0.00 | 282,992.0000 | 5,269,240 | 6.50% | 0.33% |
| Jan. 29, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | A | Warrants | 124500 | $0.00 | 124,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 29, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | A | Warrants | 62250 | $0.00 | 62,250.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | P | Common Stock | 124500 | $0.80 | 265,720.0000 | 0 | 88.16% | 0.00% |
| July 10, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | M | Common Stock | 644 | $0.00 | 141,502.0000 | 0 | 0.46% | 0.00% |
| April 5, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | F | Common Stock | 518 | $2.79 | 140,858.0000 | 0 | 0.37% | 0.00% |
| April 5, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | M | Common Stock | 1675 | $0.00 | 141,376.0000 | 0 | 1.20% | 0.00% |
| July 10, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | F | Common Stock | 282 | $1.71 | 141,220.0000 | 0 | 0.20% | 0.00% |
| June 28, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | A | Restricted Stock Units | 3233 | $0.00 | 21,922.0000 | 0 | 17.30% | 0.00% |
| June 28, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | A | Restricted Stock Units | 2425 | $0.00 | 24,347.0000 | 0 | 11.06% | 0.00% |
| June 28, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | A | Restricted Stock Units | 404 | $0.00 | 24,751.0000 | 0 | 1.66% | 0.00% |
| June 28, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | A | Restricted Stock Units | 404 | $0.00 | 25,155.0000 | 0 | 1.63% | 0.00% |
| Jan. 1, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | M | Restricted Stock Units | 1675 | $0.00 | 19,333.0000 | 0 | 7.97% | 0.00% |
| Jan. 1, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | F | Common Stock | 518 | $2.79 | 140,859.0000 | 0 | 0.37% | 0.00% |
| Jan. 1, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | M | Common Stock | 1675 | $0.00 | 141,377.0000 | 0 | 1.20% | 0.00% |
| Feb. 7, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | P | Common Stock | 21000 | $2.45 | 139,702.0000 | 0 | 17.69% | 0.00% |
| Feb. 6, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Young David | Pres. Research & Development | P | Common Stock | 20000 | $2.53 | 118,702.0000 | 0 | 20.26% | 0.00% |